RE:RE:RE:RE:RE:RE:RE:Start of new week recapSince the Phase 1b pancreatic cancer study involving Keytruda, which required ONCY to purchase Keytruda from Merck at full retail cost, ONCY went on to develop a supply agreement with Roche, which was a normal agreement where both parties supplied each other's product, atezolizumab from Roche and pelareorep from ONCY at no cost, in pursuit of a common clinical trial goal, which began with the Phase 1/2 Goblet basket studies in multple cancer that includes pancreatic, anal, colorectal and GI cancers.
ONCY has come a long way from the first IND in pancreatic cancer in combination with any immune checkpoints inhibitor.